Lothar Roessig

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction

Paul W. Armstrong, Burkert Pieske, Kevin J. Anstrom et al. · New England Journal of Medicine · 2020 · 1.3K citations · Full text

Medicine, Cardiology, Pharmacology +11

Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction

Mihai Gheorghiade, Stephen J. Greene, Javed Butler et al. · JAMA · 2015 · 390 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study

Burkert Pieske, Aldo P. Maggioni, Carolyn S.P. Lam et al. · European Heart Journal · 2016 · 357 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Riociguat for Patients With Pulmonary Hypertension Caused by Systolic Left Ventricular Dysfunction

Diana Bonderman, Stefano Ghio, Stephan B. Felix et al. · Circulation · 2013 · 325 citations

Medicine, Pharmacology, Pharmacotherapy +16

Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction

Paul W. Armstrong, Carolyn S.P. Lam, Kevin J. Anstrom et al. · JAMA · 2020 · 275 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +17